Abstract
The molecules involved in the capturing, rolling, adhesion, and locomotion steps of leukocyte emigration have been described in earlier chapters in this book. PECAM is primarily involved in diapedesis — the step in which leukocytes squeeze in ameboid fashion between the tightly apposed endothelial cells that line the blood vessels at a site of inflammation. It is also the “point of no return” for the leukocyte. In vivo as viewed by intravital microscopy, the preceding steps of capturing, rolling, locomotion, and adhesion are reversible. Most leukocytes that enter a postcapillary venule at the site of inflammation are not captured; many of the leukocytes that do adhere to the endothelium release back into the circulation. Once the leukocyte commits to diapedesis, however, it continues to migrate into the inflamed tissue and does not return to the circulation — at least not as the same cell.
Keywords
- Transendothelial Migration
- Intratracheal Instillation
- Postcapillary Venule
- Platelet Endothelial Cell Adhesion
- Homophilic Interaction
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Coxon A, Tang T, Mayadas TN (1999) Cytokine-activated endothelial cells delay neutrophil apoptosis in vitro and in vivo. A role for granulocyte/macrophage colony-stimulating factor. J Exp Med 190: 923–934
Randolph GJ, Inaba K, Robbiani DF, Steinman RM, Muller WA (1999) Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 11: 753–761
Newman PJ, Berndt MC, Gorski J, White GC II, Lyman S, Paddock C, Muller WA (1990) PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 247: 1219–1222
Newman PJ (1999) Switched at birth: A new family for PECAM-1. J Clin Invest 103: 5–9
Muller WA, Ratti CM, McDonnell SL, Cohn ZA (1989) A human endothelial cellrestricted, externally disposed plasmalemmal protein enriched in intercellular junctions. J Exp Med 170: 399–414
Newman PJ, Newman DK (2003) Signal transduction pathways mediated by PECAM-1: New roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol 23: 953–964
Ilan N, Madri JA (2003) PECAM-1: old friend, new partners. Curr Optn Cell Biol 15: 515–524
Zocchi MR, Poggi A (2004) PECAM-1, apoptosis and CD34+ precursors. Leuk Lymphoma 45: 2205–2213
Wong MX, Jacson DE (2004) Regulation of B cell activation by PECAM-1: implications for the development of autoimmune disease. Curr Pharm Des 10: 155–161
Sun Q-H, Delisser HM, Zukowski MM, Paddock C, Albelda SM, Newman PJ (1996) Individually distinct Ig homology domains in PECAM-1 regulate homophilic binding and modulate receptor affinity. J Biol Chem 271: 11090–11098
Muller WA, Berman ME, Newman PJ, De Lisser HM, Albelda SM (1992) A heterophilic adhesion mechanism for platelet/endothelial cell adhesion molecule 1 (CD31). J Exp Med 175: 1401–1404
Piali L, Hammel P, Uherek C, Bachmann F, Gisler R, Dunon D, Imhof B (1995) CD31/ PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium. J Cell Biol 130: 451–460
Wong CW, Wiedle G, Ballestrem C, Wehrle-Haller B, Etteldorf S, Bruckner M, Engelhardt B, Gisler RH, Imhof BA (2000) PECAM-1/CD31 trans-homophilic binding at the intercellular junctions is independent of its cytoplasmic domain; evidence for heterophilic interaction with integrin αvβ3 in cis. Mol Biol Cell 11: 3109–3121
Delisser HM, Yan HC, Newman PJ, Muller WA, Buck CA, Albelda SM (1993) Platelet/ endothelial cell adhesion molecule-1 (CD31)-mediated cellular aggregation involves cell surface glycosaminoglycans. J Biol Chem 268: 16037–16046
Liao F, Huynh HK, Eiroa A, Greene T, Polizzi E, Muller WA (1995) Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J Exp Med 182: 1337–1343
Sun Q-H, Paddock C, Visentin GP, Zukowski MM, Muller WA, Newman PJ (1998) Cell surface glycosaminoglycans do not serve as ligands for PECAM-1. PECAM-1 is not a heparin-binding protein. J Biol Chem 273: 11483–11490
Deaglio S, Morra M, Mallone R, Ausiello CM, Prager E, Garbarino G, Dianzani U, Stockinger H, Malavasi F (1998) Human CD38 (ADP-ribosyl cyclase) is a counterreceptor of CD31, an Ig superfamily member. J Immunol 160: 395–402
Falati S, Patil S, Gross PL, Stapleton M, Merrill-Skoloff G, Barrett NE, Pixton KL, Weiler H, Cooley B, Newman DK et al (2006) Platelet PECAM-1 inhibits thrombus formation in vivo. Blood 107: 535–541
Wee JL, Jackson DE (2005) The Ig-ITIM superfamily member PECAM-1 regulates the “outside-in” signaling properties of integrin alpha(IIb)beta3 in platelets. Blood 106: 3816–3823
Osawa M, Masuda M, Kusano K-I, Fujiwara K (2002) Evidence for a role of platelet endothelial cell adhesion molecule-1 in endothelial cell mechanosignal transduction: is it a mechanoresponsive molecule? J Cell Biol 158: 773–785
Tzima E, Irani-Tehrani M, Kiosses WB, Dejana E, Schultz DA, Engelhardt B, Cao G, DeLisser H, Schwartz MA (2005) A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 437: 426–431
Muller WA, Weigl SA, Deng X, Phillips DM (1993) PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 178: 449–460
Schenkel AR, Mamdouh Z, Muller WA (2004) Locomotion of monocytes on endothelium is a critical step during extravasation. Nat Immunol 5: 393–400
Liao F, Ali J, Greene T, Muller WA (1997) Soluble domain 1 of platelet-endothelial cell adhesion molecule (PECAM) is sufficient to block transendothelial migration in vitro and in vivo. J Exp Med 185: 1349–1357
Muller WA, Greene T, Liao F (1997) Transendothelial migration and interstitial migration of monocytes are mediated by separate domains of monocyte CD31. In: T Kishimoto (ed): Leukocyte Typing VI. Proceedings of the VIth International Leukocyte Differentiation Antigen Workshop, Kobe, Japan, 1996. Garland Publishers, London, 370–372
Nakada MT, Amin K, Christofidou-Solomidou M, O’Brien CD, Sun J, Gurubhagavatula I, Heavner GA, Taylor AH, Paddock C, Sun QH et al (2000) Antibodies against the first Ig-like domain of human platelet endothelial cell adhesion molecule-1 (PECAM-1) that inhibit PECAM-1-dependent homophilic adhesion block in vivo neutrophil recruitment. J Immunol 164: 452–462
Newton JP, Buckley CD, Jones EY, Simmons DL (1997) Residues on both faces of the first immunoglobulin fold contribute to homophilic binding sites of PECAM-1/CD31. J Biol Chem 272: 20555–20563
Schenkel AR, Mamdouh Z, Chen X, Liebman RM, Muller WA (2002) CD99 plays a major role in the migration of monocytes through endothelial junctions. Nat Immunol 3: 143–150
Allport JR, Muller WA, Luscinskas FW (2000) Monocytes induce reversible focal changes in vascular endothelial cadherin complex during transendothelial migration under flow. J Cell Biol 148: 203–216
Berman ME, Xie Y, Muller WA (1996) Roles of platelet/endothelial cell adhesion molecule-1 (PECAM-1, CD31) in natural killer cell transendothelial migration and beta 2 integrin activation. J Immunol 156: 1515–1524
Bird IN, Spragg JH, Ager AH, Matthews N (1993) Studies of lymphocyte transendothelial migration: analysis of migrated cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO. Immunology 80: 553–560
Xie Y, Muller WA (1993) Molecular cloning and adhesive properties of murine platelet/ endothelial cell adhesion molecule-1. Proc Natl Acad Sci USA 90: 5569–5573
Bogen S, Pak J, Garifallou M, Deng X, Muller WA (1994) Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. J Exp Med 179: 1059–1064
Liao F, Schenkel AR, Muller WA (1999) Transgenic mice expressing different levels of soluble platelet/endothelial cell adhesion molecule-IgG display distinct inflammatory phenotypes. J Immunol 163: 5640–5648
Muller WA, Randolph GJ (1999) Migration of leukocytes across endothelium and beyond: Molecules involved in the transmigration and fate of monocytes. J Leukoc Biol 66: 698–704
Ishikawa J, Okada Y, Bird IN, Jasani B, Spragg JH, Yamada T (2002) Use of anti-plate — let-endothelial cell adhesion molecule-1 antibody in the control of disease progression in established collagen-induced arthritis in DBA/1J mice. Jpn J Pharmacol 88: 332–340
Vaporciyan AA, Delisser HM, Yan H-C, Mendiguren II, Thorn SR, Jones ML, Ward PA, Albelda SM (1993) Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 161: 1580–1582
Gumina RJ, Schultz JE, Yao Z, Kenny D, Warltier DC, Newman PJ, Gross GJ (1996) Antibody to platelet/endothelial cell adhesion molecule-1 reduces myocardial infarct size in a rat model of ischemia-reperfusion injury. Circulation 94: 3327–3333
Murohara T, Delyam JA, Albelda SM, Lefer AM (1996) Blockade of platelet endothelial cell adhesion molecule-1 protects against myocardial ischemia and reperfusion injury in cats. J Immunol 156: 3550–3557
Qing Z, Sandor M, Radvany Z, Sewell D, Falus A, Potthoff D, Muller WA, Fabry Z (2001) Inhibition of antigen-specific T cell trafficking into the central nervous system via blocking PECAM1/CD31 molecule. J Neuropathol Exp Neurol 60: 798–807
Duncan GS, Andrew DP, Takimoto H, Kaufman SA, Yoshida H, Spellberg J, Luis de la Pompa J, Elia A, Wakeham A, Karan-Tamir B et al (1999) Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J Immunol 162: 3022–3030
Schenkel AR, Chew TW, Muller WA (2004) Platelet endothelial cell adhesion molecule deficiency or blockade significantly reduces leukocyte emigration in a majority of mouse strains. J Immunol 173: 6403–6408
Schenkel AR, Chew TW, Chlipala E, Harbord MW, Muller WA (2006) Different susceptibilities of PECAM-deficient mouse strains to spontaneous idiopathic pneumonitis. Exp Mol Pathol 81: 23–30
Thompson RD, Noble KE, Larbi KY, Dewar A, Duncan GS, Mak TW, Nourshargh S (2001) Platelet-endothelial cell adhesion molecule-1 (PECAM-1 (-deficient mice demonstrate a transient and cytokine-specific role for PECAM-1 in leukocyte migration through the perivascular basement membrane. Blood 97: 1854–1860
Thompson RD, Wakelin MW, Larbi KY, Dewar A, Asimakopoulous G, Horton MA, Nakada MT, Nourshargh S (2000) Divergent effects of platelet-endothelial cell adhesion molecule-1 and α3 integrin blockade on leukocyte transmigration in vivo. J Immunol 165:426–434
Albelda SM, Lau KC, Chien P, Huang Z, Arguiris E, Bohen A, Sun J, Billet JA, Christofidou-Solomidou M, Indik ZK et al (2004) Role for platelet-endothelial cell adhesion molecule-1 in macrophage Fcy receptor function. Am J Respir Cell Mol Biol 31: 246–255
Wakelin MW, Sanz M-J, Dewar A, Albelda SM, Larkin SW, Boughton-Smith N, Williams TJ, Nourshargh S (1996) An anti-platelet/endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through basement membrane. J Exp Med 184: 229–239
Lou O, Alcaide P, Luscinskas FW, Muller WA (2007) CD99 is a key mediator of the transendothelial migration of neutrophils. J Immunol 178: 1136–1143
Huang MT, Larbi KY, Scheiermann C, Woodfin A, Gerwin N, Haskard DO, Nourshargh S (2006) ICAM-2 mediates neutrophil transmigration in vivo: evidence for stimulus specificity and a role in PECAM-1-independent transmigration. Blood 107: 4721–4727
Tada Y, Koarada S, Morito F, Ushiyama O, Haruta Y, Kanegae F, Ohta A, Ho A, Mak TW, Nagasawa K (2003) Acceleration of the onset of collagen-induced arthritis by a deficiency of platelet endothelial cell adhesion molecule 1. Arthritis Rheum 48: 3280–3290
Graesser D, Solowiej A, Bruckner M, Osterweil E, Juedes A, Davis S, Ruddle NH, Engelhardt B, Madri JA (2002) Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J Clin Invest 109: 383–392
Wong MX, Hayball JD, Hogarth PM, Jackson DE (2005) The inhibitory co-receptor, PECAM-1 provides a protective effect in suppression of collagen-induced arthritis. J Clin Immunol 25: 19–28
Newman DK, Hamilton C, Newman PJ (2001) Inhibition of antigen-receptor signaling by platelet endothelial cell adhesion molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck). Blood 97: 2351–2357
Mamdouh Z, Chen X, Pierini LM, Maxfield FR, Muller WA (2003) Targeted recycling of PECAM from endothelial cell surface-connected compartments during diapedesis. Nature All: 748–753
Cepinskas G, Savickiene J, Ionescu CV, Kvietys PR (2003) PMN transendothelial migration decreases nuclear NFkappaB in IL-lbeta-activated endothelial cells: role of PECAM-1. J Cell Biol 161: 641–651
Tanaka Y, Albelda SM, Horgan KJ, Van Seventer GA, Shimizu Y, Newman W, Hallam J, Newman PJ, Buck CA, Shaw S (1992) CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion. J Exp Med 176: 245–253
Berman ME, Muller WA (1995) Ligation of platelet/endothelial cell adhesion molecule 1 (PECAM-1/CD31) on monocytes and neutrophils increases binding capacity of leukocyte CR3 (CDllb/CD18). J Immunol 154: 299–307
Chiba R, Nakagawa N, Kurasawa K, Tanaka Y, Saito Y, Iwamoto I (1999) Ligation of CD31 (PECAM-1) on endothelial cells increases adhesive function of αvα5 integrin and enhances β1 integrin-mediated adhesion of eosinophils to endothelial cells. Blood 94: 1319–1329
Reedquist KA, Ross E, Koop EA, Wolthuis RMF, Zwartkruis FJT, Kooyk Yv, Salmon M, Buckley CD, Bos JL (2000) The small GTPase, Rap1, mediates CD31-induced integrin adhesion. J Cell Biol 148: 1151–1158
Dangerfield J, Larbi KY, Huang MT, Dewar A, Nourshargh S (2002) PECAM-1 (CD31) homophilic interaction up-regulates alpha6beta 1 on transmigrated neutrophils in vivo and plays a functional role in the ability of α6β1 integrins to mediate leukocyte migration through the perivascular basement membrane. J Exp Med 196: 1201–1211
Reymond N, Imbert AM, Devilard E, Fabre S, Chabannon C, Xerri L, Farnarier C, Cantoni C, Bottino C, Moretta A et al (2004) DNAM-1 and PVR regulate monocyte migration through endothelial junctions. J Exp Med 199: 1331–1341
Muller WA (2003) Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol 24: 326–333
Miller M, Sung K-LP, Muller WA, Cho JY, Roman M, Castaneda D, Nayar J, Condon T, Kim J, Sriramarao P et al (2001) Eosinophil tissue recruitment to sites of allergic inflammation in the lung is platelet endothelial cell adhesion molecule independent. J Immunol 167:2292–2297
Scalia R, Lefer AM (1998) In vivo regulation of PECAM-1 activity during acute endothelial dysfunction in the rat mesenteric microvasculature. J Leukoc Biol 64: 163–169
Turegun M, Gudemez E, Newman P, Zins J, Siemionow M (1999) Blockade of platelet endothelial cell adhesion molecule-1 (PECAM-1) protects against ischemia-reperfusion injury in muscle flaps at microcirculatory level. Plast Reconstr Surg 104: 1033–1040
Tasaka S, Qin L, Saijo A, Albelda SM, De Lisser HM, Doerschuk CM (2003) Platelet endothelial cell adhesion molecule-1 in neutrophil emigration during acute bacterial pneumonia in mice and rats. Am J Respir Crit Care Med 167: 164–170
Chosay JG, Fisher MA, Farhood A, Ready KA, Dunn CJ, Jaeschke H (1998) Role of PECAM-1 (CD31) in neutrophil transmigration in murine models of liver and peritoneal inflammation. Am J Physiol 274: G776–782
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Birkhäuser Verlag Basel/Switzerland
About this chapter
Cite this chapter
Muller, W.A. (2007). PECAM: Regulating the start of diapedesis. In: Ley, K. (eds) Adhesion Molecules: Function and Inhibition. Progress in Inflammation Research. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-7975-9_8
Download citation
DOI: https://doi.org/10.1007/978-3-7643-7975-9_8
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-7974-2
Online ISBN: 978-3-7643-7975-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)